Abstract:Abstract Objective How do subclinical hemorrhages into nonfunctioning pituitary adenomas (NFPAs) influence the hormonal status and surgical outcomes remains unclear, our study aim at evaluating its definite effects on pituitary gland function and surgical outcomes. Methods All 103 consecutive patients who underwent initial endoscopic endonasal approach (EEA) for NFPAs resection from June 2016 to June 2018 were retrospectively reviewed, depending on magnetic resonance imaging (MRI), operative and pathological findings, patients were divided into the non-hemorrhagic NFPAs group and the subclinical hemorrhagic NFPAs group. A comparative analysis was conducted between these two groups to investigate the effects of subclinical hemorrhages in NFPAs on pituitary endocrine function and surgical outcomes. Results The incidence of subclinical hemorrhage on NFPAs was 22.3% (23/103), which was more frequently observed in larger adenomas (28.9 ± 9.6 mm vs 19.2 ± 9.2 mm, p = 0.001). The incidence of preoperative hypopituitarism was 69.6% (16/23) for subclinical hemorrhagic NFPAs group and 31% (25/80) for non-hemorrhagic NFPAs group (p = 0.001), a high incidence of hypopituitarism for subclinical hemorrhagic NFPAs finally was found to be owing to the large tumor rather than the intratumoral hemorrhage. All those NFPAs were resected via EEA with the technology of extra-pseduocapusual dissection in a standard elective fashion. Postoperatively, there were more than 75.6% of patients with preoperative hypopituitarism had at least one axis recovered, with hyperprolactinemia resolved in 91.7% of patients, 94.7% headaches and 90% visual symptoms resolved or improved after surgery, there was no significant difference between these two groups (p > 0.05), indicates there was no any surgical outcome difference between NFPAs with or without subclinical hemorrhage. A very low postoperative complication was achieved with new postoperative anterior pituitary failure occurred in 9.7% of patients and permanent diabetes insipidus (DI) occurred in 9.7% of patients, which advocated that EEA can be chosen as a safe surgical treatment for subclinical hemorrhagic NFPAs. Furthermore, with the technology of extra-pseduocapusual dissection, more than 87% subclinical hemorrhagic NFPAs had achieved gross total resection (GTR) with a low incidence of new postoperative hypopituitarism (14%). Conclusion Subclinical hemorrhage in NFPAs does not aggravate pituitary gland function. A surgical management strategy by EEA with the technology of extra-pseduocapusual dissection for the subclinical hemorrhagic NFPAs usually yields satisfactory endocrine and surgical outcomes, but it does not necessitate emergent tumor decompression.

Cause analysis and management of hemorrhage in trans-naso-sphenoidal surgery for pituitary adenomas

Post-operative hemorrhage after transsphenoidal surgery in patients with pituitary adenoma:a retrospective analysis

Clinical analysis and treatment of nasal complications after transsphenoidal pituitary adenomasectomy

Complications and Prevention of Single-Nostril Transsphenoidal Surgery for Pituitary Adenomas

Postoperative Complications of Endoscopic Transsphenoidal Pituitary Adenoma Resection

Emergency Transsphenoidal Surgery for Hemorrhagic Pituitary Adenomas

Differences in Clinical Characteristics and Surgical Outcomes of Patients with Ischemic and Hemorrhagic Pituitary Adenomas

Clinical Analysis of Frequently Problems after Transsphenoidal Resection of Pituitary Adenomas

Acute Hemorrhagic Apoplectic Pituitary Adenoma: Endoscopic Management, Surgical Outcomes, and Complications

Subclinical Hemorrhagic Nonfunctionning Pituitary Adenoma: Pituitary Gland Function Status, Endoscopic Endonasal Transsphenoidal Surgery, and Outcomes

Transsphenoidal microsurgery for recurrent pituitary adenoma

Transnasal Endoscopic Surgery for Pituitary Adenomas

Hemorrhagic Pituitary Macroadenoma: Characteristics, Endoscopic Endonasal Transsphenoidal Surgery, and Outcomes

Analyses and Treatments of Postoperative Nasal Complications after Endonasal Transsphenoidal Resection of Pituitary Neoplasms

Clinical Analysis of Microsurgically Treating Pituitary Apoplexy through Endonasal Transsphenoidal Approach

Clinical efficacy analysis of transsphenoidal neuroendoscopic surgery for pituitary adenoma

Internal carotid artery injury during endoscopic transsphenoidal pituitary surgery: risk factors, management

[Clinical Analysis of 6 Cases with Subarachnoid Hemorrhage During Transsphenoidal Surgery for Lesions of Sellar Region].

The Transsphenodial Microsurgery with Unilateral Incision of Endonasal Mucosa for Pituitary Adenomas

Endoscopic single nostril transsphenoidal surgery for pituitary adenoma

The Surgical Strategy and Technique of Direct Endonasal Transsphenoidal Approach for Removal of Pituitar Adenoma Apoplexy